CIALIS - AN OVERVIEW

In October 2007, the FDA introduced that the labeling for all PDE5 inhibitors, which include tadalafil, requires a more prominent warning of your potential possibility of sudden hearing loss as the result of article-promoting reviews of temporary deafness associated with usage of PDE5 inhibitors.[19]Heart problems. Sexual action has an influence on